Key result
Left atrial enlargement may refine cerebrovascular disease risk stratification, particularly in patients without AF.
Why the study?
Left atrial enlargement is linked to adverse cardiovascular outcomes including stroke, but its independent role in the pathogenesis of cerebrovascular disease, especially in patients without AF, remains unclear.
Left atrial enlargement may help refine the stratification of cerebrovascular disease risk in patients without atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May refine cerebrovascular risk stratification in cohort data; hypothesis-generating and requires prospective validation before practice change.
Left atrial enlargement (LAE) is a cardiac structural abnormality linked to adverse cardiovascular outcomes, including stroke. However, its independent role in the pathogenesis of cerebrovascular disease, especially in patients without atrial fibrillation (AF), remains unclear.
No takes yet. Share an insight, caveat, or question.
Clerici et al. (2026) studied this question. Left atrial enlargement may help refine the stratification of cerebrovascular disease risk, particularly in patients without atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: